Cargando…
Zika Virus NS3 Protease Pharmacophore Anchor Model and Drug Discovery
Zika virus (ZIKV) of the flaviviridae family, is the cause of emerging infections characterized by fever, Guillain-Barré syndrome (GBS) in adults and microcephaly in newborns. There exists an urgent unmet clinical need for anti-ZIKV drugs for the treatment of infected individuals. In the current wor...
Autores principales: | Pathak, Nikhil, Kuo, Yi-Ping, Chang, Teng-Yuan, Huang, Chin-Ting, Hung, Hui-Chen, Hsu, John Tsu-An, Yu, Guann-Yi, Yang, Jinn-Moon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265434/ https://www.ncbi.nlm.nih.gov/pubmed/32488021 http://dx.doi.org/10.1038/s41598-020-65489-w |
Ejemplares similares
-
Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection
por: Pathak, Nikhil, et al.
Publicado: (2017) -
Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication()
por: Lin, Wen-Wei, et al.
Publicado: (2023) -
Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in “Super-Open” Conformation
por: Meewan, Ittipat, et al.
Publicado: (2023) -
Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease
por: Kumar, Ankur, et al.
Publicado: (2018) -
Zika Virus Targeting by Screening Inhibitors against NS2B/NS3 Protease
por: Choudhry, Hani, et al.
Publicado: (2019)